Quarterly report · Q2

Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardIFRS
ConsolidatedYes
Data checks17 of 17 passed
Key figures · 65
MetricValuePeriodScopeSource row
Revenue¥5.0bn2022-01-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥4.6bn2022-04-01 → 2022-06-30dCons.Revenue IFRS
Revenue¥9.4bn2021-01-01 → 2021-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.9bn2021-01-01 → 2021-06-30Cons.Revenue IFRS
Revenue¥1.4bn2021-04-01 → 2021-06-30dCons.Revenue IFRS
Operating income−¥1.6bn2022-01-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income−¥393m2022-04-01 → 2022-06-30dCons.Operating profit loss IFRS
Operating income¥436m2021-01-01 → 2021-06-30Cons.Operating profit loss IFRS
Operating income¥442m2021-04-01 → 2021-06-30dCons.Operating profit loss IFRS
Profit before tax−¥1.5bn2022-01-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax−¥361m2022-04-01 → 2022-06-30dCons.Profit loss before tax IFRS
Profit before tax¥3.8bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥312m2021-01-01 → 2021-06-30Cons.Profit loss before tax IFRS
Profit before tax¥352m2021-04-01 → 2021-06-30dCons.Profit loss before tax IFRS
Net income (owners)−¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥227m2022-04-01 → 2022-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.6bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥8m2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥213m2021-04-01 → 2021-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income−¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss IFRS
Net income−¥227m2022-04-01 → 2022-06-30dCons.Profit loss IFRS
Net income¥2.6bn2021-01-01 → 2021-12-31Cons.Profit loss IFRS (5-year summary)
Net income−¥8m2021-01-01 → 2021-06-30Cons.Profit loss IFRS
Net income¥213m2021-04-01 → 2021-06-30dCons.Profit loss IFRS
Total assets¥51.9bnat 2022-06-30Cons.Assets IFRS
Total assets¥27.0bnat 2021-12-31Cons.Assets IFRS
Total assets¥24.8bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total assets¥26.1bnat 2020-12-31dCons.Assets IFRS
Total liabilities¥27.2bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥1.7bnat 2021-12-31Cons.Liabilities IFRS
Total liabilities¥4.9bnat 2020-12-31dCons.Liabilities IFRS
Net assets / equity¥24.7bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥25.4bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥22.6bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥21.3bnat 2020-12-31dCons.Equity IFRS
Equity (owners)¥24.7bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥25.4bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥22.6bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥21.3bnat 2020-12-31dCons.Equity attributable to owners of parent IFRS
Cash & equivalents¥6.4bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥11.7bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥11.8bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥7.1bnat 2020-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥10m2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥6.7bn2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥5.0bn2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥26.7bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥2.3bn2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥450m2021-01-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥21.6bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥66m2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥45m2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-8.132022-01-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-1.752022-04-01 → 2022-06-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥19.962021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-0.072021-01-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥1.662021-04-01 → 2021-06-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-8.132022-01-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-1.752022-04-01 → 2022-06-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥19.812021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-0.072021-01-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥1.642021-04-01 → 2021-06-30dCons.Diluted earnings loss per share IFRS
Equity ratio47.7%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio93.8%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio91.3%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 9
SegmentItemPeriodValue
jpcrp040300-q2r_E27486-000Drug Discovery And Development Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E27486-000Drug Discovery And Development Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E27486-000Drug Discovery And Development Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥1.4bn
jpcrp040300-q2r_E27486-000Radiopharmaceuticals Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥3.9bn
jpcrp040300-q2r_E27486-000Radiopharmaceuticals Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥3.9bn
jpcrp040300-q2r_E27486-000Radiopharmaceuticals Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥198m
—segment totalrevenue2022-01-01 → 2022-06-30¥5.0bn
—segment totalrevenue external2022-01-01 → 2022-06-30¥5.0bn
—segment totalsegment profit2022-01-01 → 2022-06-30−¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 668
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)有限責任 あずさ監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)上 野  直 樹
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)猪 俣  雅 弘
Number of submissionFilingDateInstant1
Revenue IFRS (5-year summary)Prior1YTDDuration2916946000JPY
Revenue IFRS (5-year summary)CurrentYTDDuration5024397000JPY
Revenue IFRS (5-year summary)Prior1YearDuration9422214000JPY
Revenue IFRS (5-year summary)Prior1QuarterDuration1439144000JPY
Revenue IFRS (5-year summary)CurrentQuarterDuration4604870000JPY
Profit loss before tax IFRS (5-year summary)Prior1YTDDuration312177000JPY
Profit loss before tax IFRS (5-year summary)CurrentYTDDuration-1484964000JPY
Profit loss before tax IFRS (5-year summary)Prior1YearDuration3803764000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)Prior1YTDDuration-8335000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)CurrentYTDDuration-1056081000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)Prior1YearDuration2573232000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)Prior1QuarterDuration213467000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)CurrentQuarterDuration-226784000JPY
Profit loss IFRS (5-year summary)Prior1YTDDuration-8335000JPY
Profit loss IFRS (5-year summary)CurrentYTDDuration-1056081000JPY
Profit loss IFRS (5-year summary)Prior1YearDuration2573232000JPY
Comprehensive income attributable to owners of parent IFRS (5-year summary)Prior1YTDDuration875816000JPY
Comprehensive income attributable to owners of parent IFRS (5-year summary)CurrentYTDDuration-622909000JPY
Comprehensive income attributable to owners of parent IFRS (5-year summary)Prior1YearDuration3546177000JPY
Comprehensive income IFRS (5-year summary)Prior1YTDDuration875816000JPY
Comprehensive income IFRS (5-year summary)CurrentYTDDuration-622909000JPY
Comprehensive income IFRS (5-year summary)Prior1YearDuration3546177000JPY
Equity attributable to owners of parent IFRS (5-year summary)Prior1QuarterInstant22615906000JPY
Equity attributable to owners of parent IFRS (5-year summary)CurrentQuarterInstant24739352000JPY
Equity attributable to owners of parent IFRS (5-year summary)Prior1YearInstant25350250000JPY
Total assets IFRS (5-year summary)Prior1QuarterInstant24762522000JPY
Total assets IFRS (5-year summary)CurrentQuarterInstant51895583000JPY
Total assets IFRS (5-year summary)Prior1YearInstant27034596000JPY
Basic earnings loss per share IFRS (5-year summary)Prior1YTDDuration-0.07
Basic earnings loss per share IFRS (5-year summary)CurrentYTDDuration-8.13
Basic earnings loss per share IFRS (5-year summary)Prior1YearDuration19.96
Basic earnings loss per share IFRS (5-year summary)Prior1QuarterDuration1.66
Basic earnings loss per share IFRS (5-year summary)CurrentQuarterDuration-1.75
Diluted earnings loss per share IFRS (5-year summary)Prior1YTDDuration-0.07
Diluted earnings loss per share IFRS (5-year summary)CurrentYTDDuration-8.13
Diluted earnings loss per share IFRS (5-year summary)Prior1YearDuration19.81
Ratio of owners equity to gross assets IFRS (5-year summary)Prior1QuarterInstant0.913
Ratio of owners equity to gross assets IFRS (5-year summary)CurrentQuarterInstant0.477
Ratio of owners equity to gross assets IFRS (5-year summary)Prior1YearInstant0.938
Cash flows from used in operating activities IFRS (5-year summary)Prior1YTDDuration4959002000JPY
Cash flows from used in operating activities IFRS (5-year summary)CurrentYTDDuration-9837000JPY
Cash flows from used in operating activities IFRS (5-year summary)Prior1YearDuration6654708000JPY
Cash flows from used in investing activities IFRS (5-year summary)Prior1YTDDuration-450310000JPY
Cash flows from used in investing activities IFRS (5-year summary)CurrentYTDDuration-26679922000JPY
Cash flows from used in investing activities IFRS (5-year summary)Prior1YearDuration-2283450000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 17 of 17 passed
balance sheet identityconsolidated 2020-12-31pass
balance sheet identityconsolidated 2021-12-31pass rounding
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass